Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Gowen Maxine exercised options for 11,580 Aclaris Therapeutics, Inc. shares (Form 4)
Traded Jun 5, 2026 · Filed Jun 8, 2026
On Jun 5, 2026, Gowen Maxine (Director) exercised options for 11,580 Aclaris Therapeutics, Inc. shares, leaving 33,334 shares. Filed Jun 8, 2026 (Form 4).
- Options exercised
- 11,580 shares
- Holding after
- 33,334 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Option exercise | 11,580 | 33,334 | Direct |
Source
Related
- Aclaris Therapeutics, Inc.
- Gowen Maxine
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026